Published in Cancer J on December 24, 2001
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat Genet (2001) 5.80
Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein. Cancer Res (2000) 2.32
Bronchial rupture by a double-lumen endobronchial tube during staging thoracoscopy. Anesth Analg (1999) 2.16
Transcriptional control of intestinal cytochrome P-4503A by 1alpha,25-dihydroxy vitamin D3. Mol Pharmacol (2001) 1.67
Superior sulcus (Pancoast) tumor: experience with 105 patients. Ann Thorac Surg (1998) 1.67
The MYND motif is required for repression of basal transcription from the multidrug resistance 1 promoter by the t(8;21) fusion protein. Mol Cell Biol (1998) 1.58
Global gene expression profiling in Barrett's esophagus and esophageal cancer: a comparative analysis using cDNA microarrays. Oncogene (2002) 1.54
Esophagogastrectomy for carcinoma of the esophagus and cardia: a comparison of findings and results after standard resection in three consecutive eight-year intervals with improved staging criteria. J Thorac Cardiovasc Surg (1997) 1.53
Correlation of lung surface area to apoptosis and proliferation in human emphysema. Eur Respir J (2005) 1.51
Thoracoscopic management of spontaneous pneumothorax. Chest (1992) 1.50
Microsatellite instability occurs frequently and in both diploid and aneuploid cell populations of Barrett's-associated esophageal adenocarcinomas. Cancer Res (1994) 1.49
Search for a primary lung neoplasm in patients with brain metastasis: is the chest radiograph sufficient? AJR Am J Roentgenol (1997) 1.48
Attenuating the hypertensive response to laryngoscopy and endotracheal intubation using awake fibreoptic intubation. Acta Anaesthesiol Scand (1992) 1.48
Case 6-5--1992. Anesthetic considerations for thoracoscopic procedures. J Cardiothorac Vasc Anesth (1992) 1.47
Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines. J Natl Cancer Inst (1999) 1.46
Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma. J Natl Cancer Inst (2000) 1.45
The use of carboplatin and paclitaxel with daily radiotherapy in patients with locally advanced squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys (2000) 1.44
The use of concurrent chemotherapy with high-dose radiation before surgical resection in patients presenting with apical sulcus tumors. Cancer J (2000) 1.43
A transforming growth factor beta 1 receptor type II mutation in ulcerative colitis-associated neoplasms. Gastroenterology (1997) 1.42
Clonal ordering of 17p and 5q allelic losses in Barrett dysplasia and adenocarcinoma. Proc Natl Acad Sci U S A (1993) 1.40
Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) gene. Biochim Biophys Acta (2001) 1.40
Breast cancer resistance protein directly confers SN-38 resistance of lung cancer cells. Biochem Biophys Res Commun (2001) 1.39
Use of gastrointestinal contrast studies in obstruction of the small and large bowel. Dis Colon Rectum (1990) 1.38
Hemodynamic effects of carbon dioxide insufflation during thoracoscopy. Ann Thorac Surg (1994) 1.27
Effect of bowel preparation and colonoscopy on post-procedure intestinal microbiota composition. Gut (2006) 1.22
Use of tubes and radiographs in the management of small bowel obstruction. Ann Surg (1987) 1.17
Results of cancer and leukemia group B protocol 8935. A multiinstitutional phase II trimodality trial for stage IIIA (N2) non-small-cell lung cancer. Cancer and Leukemia Group B Thoracic Surgery Group. J Thorac Cardiovasc Surg (1995) 1.14
Activation of endogenous GABAA channels on airway smooth muscle potentiates isoproterenol-mediated relaxation. Am J Physiol Lung Cell Mol Physiol (2008) 1.13
Electrocardiographic changes in cardiac patients with acute gallbladder disease. Am Surg (1986) 1.12
Expression of breast cancer resistance protein in blast cells from patients with acute leukemia. Blood (2000) 1.12
Racial and ethnic disparities in idiopathic pulmonary fibrosis: A UNOS/OPTN database analysis. Am J Transplant (2006) 1.09
Multicenter VATS experience with mediastinal tumors. Ann Thorac Surg (1998) 1.08
Delta 9-tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis. J Neuroimmunol (1989) 1.06
Insulin growth factor receptor (IGF-1R) antibody cixutumumab combined with the mTOR inhibitor temsirolimus in patients with metastatic adrenocortical carcinoma. Br J Cancer (2013) 1.06
Lung adenocarcinoma invasion in TGFbetaRII-deficient cells is mediated by CCL5/RANTES. Oncogene (2007) 1.04
Chromosome alterations in human small cell lung cancer: frequent involvement of 5q. Cancer Res (1992) 1.04
Expression of multidrug resistance-associated protein (MRP) mRNA in blast cells from acute myeloid leukemia (AML) patients. Leukemia (1996) 1.04
The 95-kilodalton membrane glycoprotein overexpressed in novel multidrug-resistant breast cancer cells is NCA, the nonspecific cross-reacting antigen of carcinoembryonic antigen. Cancer Res (1997) 1.03
From the archives of the AFIP. Malignant pleural mesothelioma: radiologic-pathologic correlation. Radiographics (1996) 1.03
Erythema and desquamation after high-dose methotrexate. Ann Intern Med (1983) 1.03
Staging, prognostic factors, and special considerations in small cell lung cancer. Semin Oncol (1988) 1.01
Skeletal muscle anabolism is a side effect of therapy with the MEK inhibitor: selumetinib in patients with cholangiocarcinoma. Br J Cancer (2012) 1.01
Methotrexate cross-resistance in a mitoxantrone-selected multidrug-resistant MCF7 breast cancer cell line is attributable to enhanced energy-dependent drug efflux. Cancer Res (2000) 1.00
Hypocalcemia precipitating congestive heart failure. N Engl J Med (1982) 1.00
A hazard of cuffed endotracheal tubes. Anaesthesia (1967) 0.97
Racial and ethnic disparities in survival in lung transplant candidates with idiopathic pulmonary fibrosis. Am J Transplant (2006) 0.97
Thoracoscopic excision of a posterior mediastinal "dumbbell" tumor using a combined approach. Ann Thorac Surg (1995) 0.96
Stuttering: an unusual side effect of phenothiazines. Am J Psychiatry (1981) 0.95
Incidental lung carcinoma detected at CT in patients selected for lung volume reduction surgery to treat severe pulmonary emphysema. Radiology (1998) 0.95
Ethylene oxide neurotoxicity: report of four cases and review of the literature. Neurology (1979) 0.93
Safe pulmonary resection after chemotherapy and high-dose thoracic radiation. Ann Thorac Surg (1999) 0.90
Frequent loss of heterozygosity on chromosome 9 in adenocarcinoma and squamous cell carcinoma of the esophagus. Cancer Res (1994) 0.90
A semiautomated technic for radioimmunoassay. Double antibody assay of insulin. Diabetes (1970) 0.87
Paraplegia after thoracotomy: report of five cases and review of the literature. Ann Thorac Surg (1995) 0.87
Thoracoscopic resection of posterior neurogenic tumors. Am Surg (1999) 0.86
Staging of carcinoma of the esophagus and cardia: a comparison of different staging criteria. J Surg Oncol (1993) 0.85
Renal and hepatic family 3A cytochromes P450 (CYP3A) in spontaneously hypertensive rats. Biochem Pharmacol (1995) 0.85
Functional analysis of long-term outcome after Heller's myotomy for achalasia. Dis Esophagus (2009) 0.85
Accuracy of CT for the detection of pleural adhesions: correlation with video-assisted thoracoscopic surgery. Chest (1999) 0.84
Etoposide: current status and future perspectives in the management of malignant neoplasms. Cancer Chemother Pharmacol (1994) 0.83
Chronic, traumatic pseudoaneurysm of the ascending aorta. Ann Thorac Surg (1992) 0.83
P53 gene protein overexpression predicts results of trimodality therapy in esophageal cancer patients. Ann Thorac Surg (1999) 0.83
Colon carcinogenesis in inflammatory bowel disease. Inflamm Bowel Dis (1995) 0.82
Creation of polarized cells coexpressing CYP3A4, NADPH cytochrome P450 reductase and MDR1/P-glycoprotein. Pharm Res (2000) 0.82
TP53 and RAS mutations in metachronous tumors from patients with cancer of the upper aerodigestive tract. Int J Cancer (1995) 0.82
The management of malignant pleural and pericardial effusions. Hematol Oncol Clin North Am (1997) 0.81
Subacute diencephalic angioencephalopathy. A clinicopathological case study. J Neurol Sci (1974) 0.81
Predictors of response and survival after concurrent chemotherapy and radiation for locally advanced squamous cell carcinomas of the head and neck. Cancer (2001) 0.81
Susceptibility of idarubicin, daunorubicin, and their C-13 alcohol metabolites to transport-mediated multidrug resistance. Biochem Pharmacol (1995) 0.80
Pharmacokinetic and pharmacodynamic study of the combination of docetaxel and topotecan in patients with solid tumors. J Clin Oncol (2000) 0.80
The role of radiologic imaging in diagnosing complications of video-assisted thoracoscopic surgery. Chest (1998) 0.80
High dose rate brachytherapy to prevent recurrent benign hyperplasia in lung transplant bronchi: theoretical and clinical considerations. J Heart Lung Transplant (2000) 0.79
Hypoalbuminemia and early mortality after lung transplantation: a cohort study. Am J Transplant (2012) 0.79
Donor surfactant protein D (SP-D) polymorphisms are associated with lung transplant outcome. Am J Transplant (2013) 0.79
VATS and thoracic oncology: anathema or opportunity. Video-assisted thoracic surgery. Ann Thorac Surg (1999) 0.79
PharmGKB update: II. CYP3A5, cytochrome P450, family 3, subfamily A, polypeptide 5. Pharmacol Rev (2004) 0.79
Heterogeneity of cytochrome P450IIIA expression in rat gut epithelia. Gastroenterology (1992) 0.79
Subarachnoid-pleural fistula after resection of a pancoast tumor with hyponatremia. Ann Thorac Surg (1995) 0.79
Extracorporeal membrane oxygenation as an adjunct treatment for primary graft failure in adult lung transplant recipients. J Thorac Cardiovasc Surg (1995) 0.78
Nodular pulmonary amyloidosis: diagnosis by fine-needle aspiration cytology and a review of the literature. Diagn Cytopathol (1993) 0.78
Combination chemotherapy with doxorubicin and mitomycin C in non-small cell bronchogenic carcinoma. Severe pulmonary toxicity from q 3 weekly mitomycin C. Am J Clin Oncol (1984) 0.78
Donor age and early graft failure after lung transplantation: a cohort study. Am J Transplant (2013) 0.77
Computed radiography in neonatal and pediatric intensive care units: a comparison of 2.5 K x 2 K soft-copy images vs digital hard-copy film. Pediatr Radiol (1996) 0.77
Generation of immunoglobulin/c-myc recombinations in murine Peyer's patch follicles. Curr Top Microbiol Immunol (1997) 0.77
Phase I study of docetaxel and topotecan in patients with solid tumors. Cancer Chemother Pharmacol (2000) 0.77
Potentiation of interferon induction of class I major histocompatibility complex antigen expression by human tumor necrosis factor in small cell lung cancer cell lines. Cancer Res (1989) 0.77
Structural and spectroscopic studies of the native hemocyanin from Maia squinado and its structural subunits. Spectrochim Acta A Mol Biomol Spectrosc (2000) 0.76
Long-term HIV infection with Crohn's disease. Am J Gastroenterol (1995) 0.76
Treatment of a bronchopleural fistula with a Fogarty catheter and oxidized regenerated cellulose (surgicel). Chest (1994) 0.76